［1］FISCHER A,BOCKSTAHLER M,MULLER AM,et al.Fn14 signaling plays a pathogenic role in a mouse model of experimental autoimmune myocarditis［J］.Journal of Cardiac Failure,2019,25(8):674-685.
［2］MARTINO LD,OSME A,KOSSAK-GUPTA S,et al.TWEAK/Fn14 is overexpressed in Crohn's disease and mediates experimental ileitis by regulating critical innate and adaptive immune pathways［J］.Cellular and Molecular Gastroenterology and Hepatology,2019,8(3):427-446.
［3］SRIVASTAVA A,LUO LL,LOHCHAROENKAL W,et al.Cross-talk between IFN-γ and TWEAK through miR-149 amplifies skin inflammation in psoriasis［J］.The Journal of Allergy and Clinical Immunology,2021,147(6):2225-2235.
［4］ZHANG YT,ZENG WH,XIA YM.TWEAK/Fn14 axis is an important player in fibrosis［J］.Journal of Cellular Physiology,2021,236(5):3304-3316.
［5］HENRY KL,KELLNER D,BAJRAMI B,et al.CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling［J］.Science Signaling,2018,11(541):eaam8216.
［6］WU ZH,NIU X,WU GH,et al.Decreased expression of TNFRSF12A in thyroid gland cancer predicts poor prognosis:A study based on TCGA data［J］.Medicine,2020,99(34):e21882.
［7］PASCOE AL,JOHNSTON AJ,MURPHY RM.Controversies in TWEAK-Fn14 signaling in skeletal muscle atrophy and regeneration［J］.Cellular and Molecular Life Sciences:CMLS,2020,77(17):3369-3381.
［8］RATAJCZAK W,ATKINSON SD,KELLY C.The TWEAK/Fn14/CD163 axis-implications for metabolic disease［J］.Reviews in Endocrine & Metabolic Disorders,2022,23(3):449-462.
［9］MENDEZ-BARBERO N,GUTIERREZ-MUNOZ C,BLAZQUEZ-SERRA R,et al.Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in cardiovascular diseases:progress and challenges［J］.Cells,2020,9(2):405.
［10］ZHAO LL,FU QS,PAN LQ,et al.The diversity and similarity of transmembrane trimerization of TNF receptors［J］.Frontiers in Cell and Developmental Biology,2020,8:569684.
［11］POVEDA J,VAZQUEZ-SANCHEZ S,SANZ AB,et al.TWEAK-Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome［J］.The Journal of Pathology,2021,254(1):5-19.
［12］GUNER G,ABFALG M,ZHAO K,et al.Proteolytically generated soluble Tweak receptor Fn14 is a blood biomarker for γ-secretase activity［J］.EMBO Molecular Medicine,2022,14(10):e16084.
［13］WANG M,XIE ZJ,XU J,et al.TWEAK/Fn14 axis in respiratory diseases［J］.Clinica Chimica Acta;International Journal of Clinical Chemistry,2020,509:139-148.
［14］PENG L,LI Q,WANG H,et al.Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model［J］.Cell Death & Disease,2018,9(8):801.
［15］CHANG WA,YEN MC,HUNG JY,et al.Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer［J］.Oncology Reports,2018,39(2):573-581.
［16］RUIZ-PLAZAS X,RODRIGUEZ-GALLEGO E,ALVES M,et al.Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness［J］.Journal of Translational Medicine,2019,17(1):307.
［17］TAN D,PANG FM,LI D,et al.Overexpression of Fn14 in gliomas:tumor progression and poor prognosis［J］.Future Oncology(London,England),2018,14(13):1273-1284.
［18］HUANG LN,ZOU Y,WU SG,et al.Fn14 Participates in neuropathic pain through NF-κB pathway in primary sensory neurons［J］.Molecular Neurobiology,2019,56(10):7085-7096.
［19］WANG W,LIU FY,WANG CY,et al.Src promotes metastasis of human non-small cell lung cancer cells through Fn14-mediated NF-κB signaling［J］.Medical Science Monitor:International Medical Journal of Experimental and Clinical Research,2018,24:1282-1294.
［20］CARR D,LAU R,HNATYKIW AD,et al.cIAP2 is an independent signaling and survival factor during mammary lactational involution and tumorigenesis［J］.Journal of Mammary Gland Biology and Neoplasia,2018,23(3):109-123.
［21］HOLMBERG R,ROBINSON M,GILBERT SF,et al.TWEAK-Fn14-RelB signaling cascade promotes stem cell-like features that contribute to post-chemotherapy ovarian cancer relapse［J］.Molecular Cancer Research:MCR,2023,21(2):170-186.
［22］KHETAN J,BARUA D.Analysis of Fn14-NF-κB signaling response dynamics using a mechanistic model［J］.Journal of Theoretical Biology,2019,480:34-42.
［23］ARMSTRONG CL,GALISTEO R,BROWN SAN,et al.TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion［J］.Oncotarget,2016,7(49):81474-81492.
［24］IACOBAS D,WEN J,IACOBAS S,et al.Remodeling of neurotransmission,chemokine,and PI3K-AKT signaling genomic fabrics in neuropsychiatric systemic lupus erythematosus［J］.Genes,2021,12(2):251.
［25］XU RD,FENG F,YU XS,et al.miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma［J］.International Journal of Immunopathology and Pharmacology,2018,32:1-12.
［26］ROOS A,DHRUV HD,MATHEWS IT,et al.Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells［J］.Oncotarget,2017,8(7):12234-12246.
［27］BURMAN P,JAISWAL R,DEVI K,et al.Aurintricarboxylic acid protects isoproterenol induced left ventricular hypertrophy by modulating TWEAK signaling［J］.Cardiovascular Pathology:The Official Journal of the Society for Cardiovascular Pathology,2022,61:107468.
［28］PAPA S,CHOY PM,BUBICI C.The ERK and JNK pathways in the regulation of metabolic reprogramming［J］.Oncogene,2019,38(13):2223-2240.
［29］LEE SJ,KIM J,KO J,et al.Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves' orbital fibroblasts［J］.PloS One,2018,13(12):e0209583.
［30］LIU W,ZHANG DW,LUO M,et al.TNF-like weak inducer of apoptosis promotes angiogenesis,thereby exacerbating cutaneous psoriatic disease［J］.The Journal of Investigative Dermatology,2021,141(5):1356-1360.
［31］XIAO GX,LYU M,WANG Y,et al.Ginkgo flavonol glycosides or ginkgolides tend to differentially protect myocardial or cerebral ischemia-reperfusion injury via regulation of TWEAK-Fn14 signaling in heart and brain［J］.Frontiers in Pharmacology,2019,10:735.
［32］WOLF J,SCHLECHT A,ROSMUS DD,et al.Comparative transcriptome analysis of human and murine choroidal neovascularization identifies fibroblast growth factor inducible-14 as phylogenetically conserved mediator of neovascular age-related macular degeneration［J］.Biochimica Et BiophysicaActa.Molecular Basis of Disease,2022,1868(4):166340.
［33］LIU J,LIU Y,PENG LL,et al.TWEAK/Fn14 signals mediate burn wound repair［J］.The Journal of Investigative Dermatology,2019,139(1):224-234.
［34］RUFFOLO C,TOFFOLATTI L,MASSANI M,et al.Interferon-gamma and tumor necrosis factor-related weak inducer of apoptosis expression in neoangiogenesis in colorectal polypoid lesions［J］.European Surgical Research,2019,60(5-6):186-195.
［35］MENDEZ-BARBERO N,GUTIERREZ-MUNOZ C,MADRIGAL-MATUTE J,et al.A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis［J］.EBioMedicine,2019,46:274-289.
［36］YANG J,MIN KW,KIM DH,et al.High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer:Gene set enrichment analysis and validation in large-scale cohorts［J］.PloS One,2018,13(8):e0202113.
［37］GUAN F,WANG L,HAO SY,et al.Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis［J］.Oncotarget,2017,8(62):105262-105275.
［38］WANG T,MA SC,QI XX,et al.Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro［J］.Molecular Medicine Reports,2017,15(3):1172-1178.
［39］LIU Q,WANG H,WANG X,et al.Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway［J］.Clinical and Experimental Immunology,2020,199(1):56-67.
［40］LIANG LL,CHENG CT,HU GL,et al.TWEAK promotes the proliferation of squamous cell carcinoma cells through activating cIAP1 signals［J］.Frontiers in Oncology,2020,10:439.
［41］WANG XN,CHENG D,HU GL,et al.Tumor necrosis factor (TNF) receptor expression determines keratinocyte fate upon stimulation with TNF-like weak inducer of apoptosis［J］.Mediators of Inflammation,2019,2019:2945083.
［42］HU GL,ZENG WH,XIA YM.TWEAK/Fn14 signaling in tumors［J］.Tumour Biology,2017,39(6):1010428317714624.
［43］WU AY,GU LY,CANG W,et al.Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation［J］.Journal of Experimental & Clinical Cancer Research,2019,38(1):176.
［44］TEZUKA Y,EGUCHI-ISHIMAE M,OZAKI E,et al.Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy［J］.PloS One,2021,16(10):e0258090.
［45］WANG SJ,LI L,COOK C,et al.A potential fate decision landscape of the TWEAK/Fn14 axis on stem and progenitor cells:a systematic review［J］.Stem Cell Research & Therapy,2022,13(1):270.
［46］CHEN Y,GAO WK,SHU YY,et al.Mechanisms of ductular reaction in non-alcoholic steatohepatitis［J］.World Journal of Gastroenterology,2022,28(19):2088-2099.
［47］CORDIDO A,NUNEZ-GONZALEZ L,MARTINEZ-MORENO JM,et al.TWEAK signaling pathway blockade slows cyst growth and disease progression in autosomal dominant polycystic kidney disease［J］.Journal of the American Society of Nephrology,2021,32(8):1913-1932.
［48］DWYER BJ,JARMAN EJ,GOGOI-TIWARI J,et al.TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression［J］.Journal of Hepatology,2021,74(4):860-872.
［49］FUKUDA T,FUKUDA R,KOINUMA D,et al.BMP2-induction of FN14 promotes protumorigenic signaling in gynecologic cancer cells［J］.Cellular Signalling,2021,87:110146.
［50］BADIA-VILLANUEVA M,DEFAUS S,FOJ R,et al.Evaluation of computationally designed peptides against TWEAK,a cytokine of the tumour necrosis factor ligand family［J］.International Journal of Molecular Sciences,2021,22(3):1066.
［51］LI LC,AMERI AH,WANG SM,et al.EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis［J］.Oncogene,2019,38(35):6241-6255.
［52］ZAITSEVA O,HOFFMANN A,OTTO C,et al.Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy［J］.Frontiers in Pharmacology,2022,13:935086.
［53］ALTUNA-COY A,RUIZ-PLAZAS X,ALVES-SANTIAGO M,et al.Serum levels of the cytokine TWEAK are associated with metabolic status in patients with prostate cancer and modulate cancer cell lipid metabolism in vitro［J］.Cancers,2021,13(18):4688.
［54］CONNOLLY NP,GALISTEO R,XU S,et al.Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer［J］.Glia,2021,69(9):2199-2214.
［55］HERSH DS,PENG S,DANCY JG,et al.Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas［J］.Journal of Neuro-Oncology,2018,138(2):241-250.
［56］HERSH DS,HARDER BG,ROOS A,et al.The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance［J］.Neuro-Oncology,2018,20(10):1321-1330.
［57］HE ZX,WANG S,WU JC,et al.Lower expression of TWEAK is associated with poor survival and dysregulate TIICs in lung adenocarcinoma［J］.Disease Markers,2022,2022:8661423.
［58］MEULENDIJKS D,LASSEN UN,SIU LL,et al.Exposure and tumor Fn14 expression as determinants of pharmacodynamics of the anti-TWEAK monoclonal antibody RG7212 in patients with Fn14-positive solid tumors［J］.Clinical Cancer Research,2016,22(4):858-867.
［59］SEZAKI T,HIRATA Y,HAGIWARA T,et al.Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice［J］.World Journal of Gastroenterology,2017,23(13):2294-2307.
［60］ZHOU H,MOHAMEDALI KA,GONZALEZ-ANGULO AM,et al.Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC［J］.Molecular Cancer Therapeutics,2014,13(11):2688-2705.
［61］CIENFUEGOS AAD,CHEUNG LH,MOHAMEDALI KA,et al.Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B［J］.Journal for Immunotherapy of Cancer,2020,8(2):e001138.
［62］WANG XY,LU M,GU HJ,et al.Conjugation of the Fn14 ligand to a SMAC mimetic selectively suppresses experimental squamous cell carcinoma in mice［J］.The Journal of Investigative Dermatology,2023,143(2):242-253.
［63］GUPTA G,KAZMI I,AL-ABBASI FA,et al.Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancer［J］.EXCLI Journal,2021,20:232-235.
［64］LAM ET,ECKHARDT SG,MESSERSMITH W,et al.Phase I study of Enavatuzumab,a first-in-class humanized monoclonal antibody targeting the TWEAK receptor,in patients with advanced solid tumors［J］.Molecular Cancer Therapeutics,2018,17(1):215-221.
［65］KESHTVARZ M,SALIMIAN J,YASERI M,et al.Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cells［J］.Immunotherapy,2017,9(5):387-400.
［66］SOMMER A,BERNDT S,LERCHEN HG,et al.Antibody-drug conjugates harboring a kinesin spindle protein inhibitor with immunostimulatory properties［J］.Oncoimmunology,2022,11(1):2037216.